Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Amer Sports, Inc. in connection with its listing on the NYSE with credit facilities and issuance of bonds
Mandate

Vinge has advised Amer Sports, Inc. in connection with its listing on the NYSE with credit facilities and issuance of bonds

March 26, 2024

Vinge has advised Amer Sports, Inc. in connection with the listing of the company on the New York Stock Exchange with 105,000,000 shares at a value of USD 1.37 billion, whereby Vinge has assisted Amer Sports, Inc. and its subsidiaries with regulatory matters and the establishment of credit facilities of USD 500 million and EUR 700 million respectively and with the issuance of USD 800 million senior secured bonds where the Swedish subsidiaries have provided certain guarantees.

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, Peak Performance and Atomic. Amer Sports has over 10,800 employees and operates in 41 countries.

 

Vinge's team consisted of Fredrik Wilkens, Henrik Schön, David Flodin, Linn Adelwald, Arvid Weimers and Jolinn Uhlin.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025